Erythromycin improves gastrointestinal motility in extremely low birthweight infants
- 1 April 1994
- journal article
- Published by Wiley in Pediatrics International
- Vol. 36 (2), 198-201
- https://doi.org/10.1111/j.1442-200x.1994.tb03161.x
Abstract
Erythromycin (EM) was administered to five extremely low birthweight infants (ELBWI) with delayed enteral feeding to evaluate the clinical effect on severely impaired gastrointestinal motility. Five patients studied responded well to EM administration without any adverse effects during the course. Four patients were given 15-30 mg/kg per day EM intravenously as a loading and thereafter 3-5 mg/kg per day as a maintenance dose. One patient responded well without loading. The infants could be fed enterally 4, 5, 6, 4 and 2 days after the initiation of EM administration, respectively. Erythromycin administration is a safe and useful way to facilitate gastrointestinal motility in ELBWI who require prolonged ventilator support with an increased risk for nutrient deprivation.Keywords
This publication has 8 references indexed in Scilit:
- Effect of early feeding on maturation of the preterm infant's small intestineThe Journal of Pediatrics, 1992
- Improvement of Gastric Emptying in Diabetic Gastroparesis by ErythromycinNew England Journal of Medicine, 1990
- Postnatal Maturation of Small Intestinal Motility in Preterm and Term InfantsNeurogastroenterology & Motility, 1989
- Gestational evolution of small intestine motility in preterm and term infantsThe Journal of Pediatrics, 1989
- Erythromycin induces migrating motor complex in human gastrointestinal tractDigestive Diseases and Sciences, 1986
- Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dogAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1984
- METABOLIC AND ENDOCRINE CONSEQUENCES OF DEPRIVING PRETERM INFANTS OF ENTERAL NUTRITIONActa Paediatrica, 1983